Here can all ESP members announce positions in their group. Contact Pål K. Selbo for more info.
Postdoctoral Opportunity: Identification of point mutation to rescue defective cystic fibrosis gene
Institute of Biophysics, National Research Council of Italy - Trento, Italy
Starting: January 1, 2019
At the Institute of Biophysics of CNR ( http://www.ibf.cnr.it/), we are looking for a bright and enthusiastic individual who is interested in CRISPR, GFP-based biosensors, live cell fluorescence and microfluidics.
This interdisciplinary project aims at identifying CFTR point mutation able to reestablish the correct level of chloride transport. The project combines CRISPR-based genome editing, biosensor microscopy and microfluidics in collaboration with Prof. A. Cereseto (www.cibio.unitn.it/97/laboratory-of-molecular-virology) and the company MicroFabSolutions (www.microfabsolutions.com).
This position requires PhD level training in biophysics, biotechnology, or similar disciplines. Previous experience with live cell microscopy, CRISPR technology or microfluidocs engineeering is desirable. The successful applicant will join a collaborative research environment.
Applications should be sent by email to Dr. Arosio at email@example.com. Applicants are requested to send a CV, representative publications, and names and contact information of three references.
Informal inquiries are welcome and do not hesitate to pass on this announcement.
2 year Post Doc position: Department of Radiation Biology, Institute for Cancer Research
Start: January 1st 2019. End: November1st 2021.
The position is linked to the NanoVax project funded by the ERA-NET EuroNanoMed III program. The project aims to develop nanoparticles for therapeutic vaccination against melanomas and the use of photochemical treatment to enhance the vaccination effect. The post doc position will take part in studies of photochemical treatment to achieve optimal vaccination effect and will primarily focus on cellular and immunological responses of treatment.
Oslo University Hospital (OUH) is Norway's largest Hospital with over 22,000 employees. The hospital has extensive activity in research, education and innovation where we are developing tomorrow's medicines and treatments. Institute for Cancer Research has since its foundation in 1954 played a central role within the field of cancer research both in Norway and internationally. The Institute has internationally strong research groups within biochemistry, cell and tumour biology, genetics, radiation biology, immunology and cancer prevention.
If you want to apply, please send us ASAP a letter including CV, list of publications and a letter(s) of recommendation.
- Investigate immune responses to photochemical treatment and therapeutic vaccination in vivo Isolation and treatment of lymph nodes In vitro assays related to vaccination against cancer
- Background in immunology primarily related to cancer vaccines FELASA C certificate and significant hands on experience with mouse models Experience with research on cells in culture
- Doctorate in Biology, Medicine or Pharmaceutics
- Personal characteristics
- Independent, Innovative, Motivated and Enthusiastic, Able to collaborate in a multidisciplinary team, Communicative
- We offer
- An engaged and enthusiastic professional environment with broad academic background. Flexible working conditions. Travel: Some travel activities may be expected
- Contact info
Professor Kristian Berg (https://www.ous-research.no/berg)
Dr Pål K. Selbo (https://www.ous-research.no/selbo)
Alternatives (in Norwegian): Finn.no code/link: 135078103 or Webcruiter Ref.nr./link: 3982764068